Laurus Labs Opening Bell Updates: Share Price Surges on Record Q1 FY27 Results

Laurus Labs (NSE: LAURUSLABS) concluded Friday's session at INR 1,601.20, marking a 2.1% advance from its previous close, and hitting an intraday all-time high of INR 1,603. The pharmaceutical major is set for a robust start to the week, opening today at INR 1,624.80. Early trading has seen the stock surge to an intraday high of INR 1,666.00, reflecting a significant pre-open indication and strong positive sentiment driven by its exceptional quarterly performance. Currently trading at INR 1,657.60, up 3.52%, the stock has clearly surpassed its prior 52-week high, suggesting a continuation of the upward momentum.

Overnight & Global Cues

Globally, markets presented a mixed picture over the weekend. US equity markets closed Friday mixed, with the S&P 500 largely unchanged, while the technology-heavy Nasdaq dipped 0.6% amid sector weakness. However, the Dow Jones Industrial Average and the Russell Midcap Index posted modest gains. Asian markets generally moved lower on Friday, also impacted by technology sector performance. Geopolitical tensions in the Middle East and new US global tariffs ranging from 10% to 12.5% remained key considerations for investors. Despite these mixed global signals, Indian equities are anticipated to open positively today, benefiting from easing geopolitical tensions. Domestically, Foreign Institutional Investors (FIIs) were net sellers in the cash segment on Friday, divesting ₹3,892.77 crore, while Domestic Institutional Investors (DIIs) provided strong support, emerging as net buyers with inflows of ₹5,453.55 crore. The broader Indian pharma sector has recently seen defensive rotation, further buoyed by India's pharma M&A market hitting a four-year high in Q2 2026, driven by a blockbuster acquisition. Stocks To Buy or Sell Today, July 27, 2026: Bank of Baroda, Lodha Developers and NTPC Among Shares That May Remain in Spotlight on Monday.

Recent Developments

Laurus Labs has delivered an "outstanding" quarterly performance for Q1 FY27 (June 2026), with its financial trend rating upgraded from very positive to outstanding. The company reported record-breaking net sales of ₹2,026.31 crore, a significant 29% year-on-year increase, complemented by a remarkable 124.7% surge in net profit after tax to ₹367.60 crore. Operational efficiency also improved significantly, with the EBITDA margin expanding to 31.50% from 24.8% a year ago. A key driver of this exceptional growth was the Contract Development and Manufacturing Organization (CDMO) segment, which saw its revenue jump 69% year-on-year to ₹835 crore. Management has also signaled confidence by raising FY27 capital expenditure guidance to ₹2,000 crore from ₹1,500 crore to meet growing customer demand. Following these robust results, some analysts have reaffirmed their positive outlook, with Deven Choksey reportedly increasing the Accumulate price target to ₹1,705.0 on July 24, 2026. The company also provided an update on a Composite Scheme of Arrangement on July 25, 2026. IDFC FIRST Bank Opening Bell Updates: Strong Q1, INR 20,000 Cr Capital Raise.

Key Levels to Watch

With today's opening at ₹1,624.80, Laurus Labs has demonstrated a strong gap-up from its previous close of ₹1,601.20. The intraday high of ₹1,666.00 now effectively serves as the new 52-week high, having comfortably surpassed the prior high of ₹1,610.00 recorded on July 24, 2026. On the downside, the 52-week low stands at ₹810.05 (August 12, 2025). Technical analysis suggests a medium-term support level around ₹1130. Traders should observe how the stock consolidates above the ₹1,600 mark, with immediate resistance potentially seen around the fresh intraday highs.

Opening Outlook

Laurus Labs appears poised for a bullish session, largely on the back of its stellar Q1 FY27 earnings, particularly the robust growth in its CDMO business. The significant pre-open price action and the stock trading at new highs underscore positive investor reaction. While global cues were mixed, the easing of geopolitical tensions and sustained DII buying could provide underlying market support. Traders will be keenly watching the sustainability of volumes and price action at higher levels. Any profit-booking in a broader market correction could bring the stock towards immediate support zones, but the strong fundamentals from the latest results are likely to keep investor interest elevated.

Disclaimer: The information provided in this article is based on news reports and is not intended as investment advice. Investing in stocks involves risk. LatestLY advises its readers to consult with a financial advisor before making any investment decisions.

(The above story first appeared on LatestLY on Jul 27, 2026 09:34 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).